N-(6-bromo-2-ethylimidazo[1,2-b]pyridazin-3-yl)-4-(4-fluorophenyl)-N-methyl-1,3-thiazol-2-amine;ethyl 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-methylamino]imidazo[1,2-b]pyridazin-6-yl]piperidine-4-carboxylate
C44H44BrF2N11O2S2 — CID 157119885
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(6-bromo-2-ethylimidazo[1,2-b]pyridazin-3-yl)-4-(4-fluorophenyl)-N-methyl-1,3-thiazol-2-amine;ethyl 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-methylamino]imidazo[1,2-b]pyridazin-6-yl]piperidine-4-carboxylate
N-(6-bromo-2-ethylimidazo[1,2-b]pyridazin-3-yl)-4-(4-fluorophenyl)-N-methyl-1,3-thiazol-2-amine;ethyl 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-methylamino]imidazo[1,2-b]pyridazin-6-yl]piperidine-4-carboxylate (PubChem CID 157119885) has the molecular formula C44H44BrF2N11O2S2 and a molecular weight of 940.94 g/mol. Its IUPAC name is N-(6-bromo-2-ethylimidazo[1,2-b]pyridazin-3-yl)-4-(4-fluorophenyl)-N-methyl-1,3-thiazol-2-amine;ethyl 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-methylamino]imidazo[1,2-b]pyridazin-6-yl]piperidine-4-carboxylate.
Molecular Properties
| Compound Name | N-(6-bromo-2-ethylimidazo[1,2-b]pyridazin-3-yl)-4-(4-fluorophenyl)-N-methyl-1,3-thiazol-2-amine;ethyl 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-methylamino]imidazo[1,2-b]pyridazin-6-yl]piperidine-4-carboxylate |
|---|---|
| PubChem CID | 157119885 |
| Molecular Formula | C44H44BrF2N11O2S2 |
| Molecular Weight | 940.94 g/mol |
| Exact Mass | 939.23 |
| IUPAC Name | N-(6-bromo-2-ethylimidazo[1,2-b]pyridazin-3-yl)-4-(4-fluorophenyl)-N-methyl-1,3-thiazol-2-amine;ethyl 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-methylamino]imidazo[1,2-b]pyridazin-6-yl]piperidine-4-carboxylate |
| SMILES | CCOC(=O)C1CCN(c2ccc3nc(CC)c(N(C)c4nc(-c5ccc(F)cc5)cs4)n3n2)CC1.CCc1nc2ccc(Br)nn2c1N(C)c1nc(-c2ccc(F)cc2)cs1 |
| InChI | InChI=1S/C26H29FN6O2S.C18H15BrFN5S/c1-4-20-24(31(3)26-29-21(16-36-26)17-6-8-19(27)9-7-17)33-22(28-20)10-11-23(30-33)32-14-12-18(13-15-32)25(34)35-5-2;1-3-13-17(25-16(21-13)9-8-15(19)23-25)24(2)18-22-14(10-26-18)11-4-6-12(20)7-5-11/h6-11,16,18H,4-5,12-15H2,1-3H3;4-10H,3H2,1-2H3 |
| InChIKey | AHVPCJUXCRHGDO-UHFFFAOYSA-N |
| XLogP | 10.19 |
| TPSA | 122.18 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 62 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 940.94 |
| LogP ≤ 5 | 10.19 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157119885 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.